FMS
Fresenius Medical Care AG & Co. KGaA · Healthcare · Medical - Care Facilities
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 67 | +2 | 17.58M | $406.40M | +8 | −6 |
| Q1 2026 | 66 | +1 | 15.50M | $355.69M | +6 | −5 |
| Q4 2025 | 65 | +2 | 12.66M | $307.70M | +2 | — |
| Q3 2025 | 11 | -2 | 8.29M | $218.30M | +1 | −3 |
| Q2 2025 | 10 | -2 | 4.91M | $140.34M | — | −2 |
| Q1 2025 | 10 | +1 | 5.53M | $137.66M | +1 | — |
| Q4 2024 | 9 | +1 | 5.46M | $123.55M | +2 | −1 |
| Q3 2024 | 8 | +2 | 4.84M | $103.66M | +3 | −1 |
| Q2 2024 | 6 | — | 4.46M | $85.11M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 4.22M | — | $80.62M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Citadel Advisors ✦ | 99.16K | — | $1.89M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 99.16K | — | $1.89M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 93.84K | — | $1.79M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 16.55K | — | $315,978 | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Marshall Wace ✦ | 15.36K | — | $293,279 | 0.0% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 10.34K | — | $197,391 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2 holders, 961.88K shares, $76.33M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.